Dr Agarwal’s Health Care IPO, opening Wednesday, aims to raise ₹3,027 crore. Offering advanced eye care services, the company plans to utilize funds for debt repayment, acquisitions, and corporate purposes. The price band is ₹382-₹402.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected